Bicalutamide BICALUMUTIDE 50 is a medication primarily used in the treatment of prostate cancer. It is sold under various brand names, including Casodex. BICALUMUTIDE 50 is classified as an antiandrogen, specifically a non-steroidal antiandrogen. Prostate cancer is often influenced by the presence of male hormones, particularly dihydrotestosterone (DHT). These hormones can stimulate the growth of prostate cancer cells. BICALUMUTIDE 50 works by blocking the action of androgens (male hormones) like DHT at the cellular level. It does this by binding to the androgen receptors on prostate cancer cells, preventing the hormones from binding to these receptors. As a result, BICALUMUTIDE 50 inhibits the growth and proliferation of prostate cancer cells. BICALUMUTIDE 50 is typically used in combination with other treatments for prostate cancer, such as surgical castration (removal of the testes) or medical castration (use of drugs to lower testosterone levels). This combination therapy is often referred to as "combined androgen blockade" or "total androgen blockade." BICALUMUTIDE 50 is administered orally in the form of tablets and is usually taken daily. It is commonly prescribed for patients with advanced prostate cancer, including those with metastatic disease or those who have not responded well to other treatments. Common side effects of BICALUMUTIDE 50 may include breast tenderness or enlargement, hot flashes, gastrointestinal symptoms (such as nausea and diarrhea), and liver function abnormalities. It's important for patients to be monitored by a healthcare provider while taking bicalutamide, and any side effects or concerns should be discussed with their medical team. For further information please contact: info@sterispharma.com order now - https://www.sterisonline.com/product/bicalumutide-50-133654